CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in NKTR — Nektar Therapeutics
CIK 884546
SAN FRANCISCO, CA
Position in NKTR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$19,893,825
+$7,805,722 QoQ
Shares Held
284,971
+69.6% QoQ
Ownership
0.835%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 239 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NKTR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. NKTR ranks #70 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in NKTR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,893,825 | 284,971 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,088,103 | 168,007 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,089,666 | 120,380 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,524,381 | 114,664 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,703,605 | 65,929 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $975,430 | 1,434,457 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $1,363,527 | 1,466,159 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,890,418 | 1,454,168 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,844,785 | 1,487,730 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,049,336 | 1,128,319 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $612,598 | 1,093,926 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $644,429 | 1,074,049 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $580,018 | 1,000,032 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $842,428 | 1,203,469 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,110,193 | 1,376,192 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,349,692 | 1,359,279 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,976,696 | 1,309,657 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $5,109,380 | 947,937 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $12,576,013 | 930,867 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $16,300,011 | 907,573 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $15,294,107 | 891,265 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $17,428,300 | 871,415 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $17,023,137 | 1,001,361 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $15,792,551 | 951,932 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $21,506,306 | 928,597 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $14,935,309 | 836,712 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||